FDA Inspection 1035308 — Esteve RD France SAS
The FDA completed an inspection of Esteve RD France SAS on September 27, 2017 in Montrouge. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 27, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Montrouge (France)
Additional Details
Postmarket Adverse Drug Experience (PADE)